Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Millennium Management LLC

Millennium Management LLC decreased its holdings in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 81.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 41,242 shares of the company's stock after selling 176,465 shares during the period. Millennium Management LLC owned about 0.23% of Addus HomeCare worth $5,170,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of ADUS. Natixis grew its holdings in shares of Addus HomeCare by 111.9% in the fourth quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after purchasing an additional 132 shares during the last quarter. Smartleaf Asset Management LLC grew its stake in Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after acquiring an additional 214 shares in the last quarter. Parkside Financial Bank & Trust increased its position in shares of Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after acquiring an additional 148 shares during the period. Meeder Asset Management Inc. purchased a new position in shares of Addus HomeCare during the fourth quarter worth approximately $77,000. Finally, Harvest Fund Management Co. Ltd bought a new stake in shares of Addus HomeCare during the fourth quarter valued at approximately $86,000. Hedge funds and other institutional investors own 95.35% of the company's stock.

Addus HomeCare Trading Down 0.7%

Shares of NASDAQ:ADUS traded down $0.82 on Friday, reaching $112.31. The company had a trading volume of 238,885 shares, compared to its average volume of 169,127. The firm has a market capitalization of $2.07 billion, a PE ratio of 25.70, a PEG ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a 52-week low of $88.96 and a 52-week high of $136.72. The firm's 50 day simple moving average is $104.45 and its 200-day simple moving average is $112.73.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. During the same quarter last year, the company earned $1.21 earnings per share. The firm's revenue for the quarter was up 20.3% compared to the same quarter last year. As a group, equities research analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Insider Activity

In other news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the completion of the sale, the executive vice president now owns 7,796 shares of the company's stock, valued at $896,540. This trade represents a 20.78% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 4.60% of the company's stock.

Wall Street Analyst Weigh In

ADUS has been the topic of several research analyst reports. Wall Street Zen cut Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. JMP Securities reissued a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Tuesday, April 22nd. Macquarie raised their price target on Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. Finally, Stephens reaffirmed an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. One analyst has rated the stock with a hold rating, six have issued a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $142.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.